We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mobile Testing Platform Performs World's Fastest Multiplex PCR and RT-PCR Analysis

By LabMedica International staff writers
Posted on 29 Jun 2022
Image: Chronos Dx platform (Photo courtesy of BforCure)
Image: Chronos Dx platform (Photo courtesy of BforCure)

Polymerase Chain Reaction (PCR) is an enzymatic amplification technique that produces a large number of identical copies of a DNA or RNA fragment and visualizes it by fluorescence. This very fast, sensitive and sequence-specific technique is much more efficient than traditional culture-based diagnostic methods, which suffer from long delays in obtaining results (from several days to several weeks). This is currently the most relevant method for rapid detection of genetic sequences in a sample, for example those of bacteria or viruses causing infectious diseases. In addition to classical PCR, there are several other types of PCR such as RT-PCR (reverse transcription PCR), qPCR (quantitative PCR), dPCR (digital PCR) and ddPCR (droplet digital PCR). Now, a new techniques named hcPCR (high content PCR), combines the advantages of qPCR and dPCR, in order to detect a large number of targets per test (multiplexing) and obtain the maximum amount of information in record time.

The hcPCR technique has been developed at BforCure (Paris, France) with Chronos Dx, its mobile, easy-to-use PCR/RT-PCR testing tool that delivers in vitro diagnosis of many infectious diseases in less than 15 minutes. While real-time PCR or RT-PCR typically takes 35 minutes to one hour to detect genetic material, BforCure's Chronos Dx platform performs multiplex PCR and RT-PCR analysis in record time. With the company’s Bflash+ range of kits optimized for research purposes, it is even possible to obtain accurate test results in less than five minutes.

Chronos Dx is based on a combination of microfluidic and optical technologies, which allows for ultra-fast temperature changes in the reaction mixture, reduced PCR cycle times and the detection of multiple genetic targets present in a sample, all in a single test (multiplexing principle). Chronos Dx enables ultra-fast PCR tests to be performed on a wide range of infectious diseases (respiratory, digestive and sexually transmitted). The infectious disease PCR testing tool offers a reliable and rapid response to the needs of laboratories regarding the detection of microorganisms, whether in the medical, environmental or industrial fields. Mobile, easy to use and connected, the Chronos Dx platform can be directly used in delocalized "satellite laboratories", as close as possible to the needs of healthcare professionals. It allows medical laboratories to manage urgent samples by performing unit analyses of numerous contagious pathologies, in order to accelerate patient care.

Related Links:
BforCure 

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit

Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more